The significance of Syndecan 1, a new marker for endothelial dysfunction, in cases of fetal growth retardation

Am J Reprod Immunol. 2024 May;91(5):e13858. doi: 10.1111/aji.13858.

Abstract

Problem: In the current study we aimed to investigate Syndecan 1 (SDC1) levels in pregnant women diagnosed with fetal growth restriction (FGR) and the relationship between SDC1 levels and clinical and doppler parameters in FGR cases associated with endothelial dysfunction, angiogenesis and uteroplacental insufficiency METHOD OF STUDY: A total of 90 pregnant women included in the study, (45 with FGR, 45 healthy control) matched by week of gestation and maternal age. Venous blood samples were collected and plasma concentrations of SDC1 were determined by a specific immunoassay. Doppler examination was performed to evaluate the relationship between the SDC1 levels and placental blood supply.

Results: Doppler parameters; mean UtA-PI (p < .001), CPR (p = .002) and CPUR (p < .001) were different between the groups, however MCA PI, umbilical artery PI and umbilical artery S/D were not (p > .05). While gestational age at delivery, birth weight, APGAR score at 1 and 5 min were significantly lower (all, p < .001) in the study group, non-reassure fetal heart rate tracing (p = .09) and NICU admission (p = .02) were significantly higher. SDC 1 level was 2,00 ± 1,47 ng/mL and 2,34 ± 1,12 ng/mL in the FGR and control groups, respectively (p = .008). In the study group SDC 1 level was 1,69 ± 2,00 in those with gestational age below 32 weeks and 2,13 ± 1,18 in those with gestational age above 32 weeks and there was a statistically significant difference between the groups (p = .015). Plasma SDC 1 concentration of 2,1850 ng/mL or less had a sensitivity of 70%, a specificity of 72%, area under the ROC curve .65 (p < .005).

Conclusions: Low maternal plasma SDC1 level may be associated with placental insufficiency and FGR. Low levels of SDC1 may be helpful as a predictor for the development of FGR during gestation.

Keywords: Syndecan 1; doppler; endothelial disfunction; fetal growth restriction; umbilical artery; uterine artery.

MeSH terms

  • Adult
  • Biomarkers* / blood
  • Endothelium, Vascular / physiopathology
  • Female
  • Fetal Growth Retardation* / blood
  • Gestational Age
  • Humans
  • Infant, Newborn
  • Placenta / metabolism
  • Pregnancy
  • Syndecan-1* / blood
  • Umbilical Arteries / diagnostic imaging

Substances

  • SDC1 protein, human